Back
- 09
- Everolimus improves progression-free survival for patients with advanced, nonfunctional neuroendocrine tumors of the lung, gastrointestinal tract
- Breakthrough study demonstrates survival advantage with immune checkpoint inhibitor for advanced kidney cancer patients
- MD Anderson study identifies leukemia tumor suppressor
- A Conversation With a Living Legend® returns to San Antonio to honor Emmitt Smith
- MD Anderson, Cayman Chemical, and Fannin Innovation Studio form therapeutics company
- MD Anderson immunologist Jim Allison wins Lasker-DeBakey Award
- MD Anderson brings Making Cancer History® seminar to Atlanta
- MD Anderson and Cellectis announce pre-clinical and clinical alliance in cancer immunotherapy
- MD Anderson to honor Houstonians for their efforts to end cancer
- Michelle Barton receives Rogers Award for Excellence in Education
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.